Correlation Between Coya Therapeutics, and Cardiff Oncology
Can any of the company-specific risk be diversified away by investing in both Coya Therapeutics, and Cardiff Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Coya Therapeutics, and Cardiff Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Coya Therapeutics, Common and Cardiff Oncology, you can compare the effects of market volatilities on Coya Therapeutics, and Cardiff Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Coya Therapeutics, with a short position of Cardiff Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Coya Therapeutics, and Cardiff Oncology.
Diversification Opportunities for Coya Therapeutics, and Cardiff Oncology
0.36 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Coya and Cardiff is 0.36. Overlapping area represents the amount of risk that can be diversified away by holding Coya Therapeutics, Common and Cardiff Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cardiff Oncology and Coya Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Coya Therapeutics, Common are associated (or correlated) with Cardiff Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cardiff Oncology has no effect on the direction of Coya Therapeutics, i.e., Coya Therapeutics, and Cardiff Oncology go up and down completely randomly.
Pair Corralation between Coya Therapeutics, and Cardiff Oncology
Given the investment horizon of 90 days Coya Therapeutics, is expected to generate 1.84 times less return on investment than Cardiff Oncology. But when comparing it to its historical volatility, Coya Therapeutics, Common is 1.34 times less risky than Cardiff Oncology. It trades about 0.04 of its potential returns per unit of risk. Cardiff Oncology is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest 122.00 in Cardiff Oncology on September 10, 2024 and sell it today you would earn a total of 109.00 from holding Cardiff Oncology or generate 89.34% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 98.79% |
Values | Daily Returns |
Coya Therapeutics, Common vs. Cardiff Oncology
Performance |
Timeline |
Coya Therapeutics, Common |
Cardiff Oncology |
Coya Therapeutics, and Cardiff Oncology Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Coya Therapeutics, and Cardiff Oncology
The main advantage of trading using opposite Coya Therapeutics, and Cardiff Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Coya Therapeutics, position performs unexpectedly, Cardiff Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cardiff Oncology will offset losses from the drop in Cardiff Oncology's long position.Coya Therapeutics, vs. Cue Biopharma | Coya Therapeutics, vs. Lantern Pharma | Coya Therapeutics, vs. Fennec Pharmaceuticals | Coya Therapeutics, vs. Eliem Therapeutics |
Cardiff Oncology vs. Reviva Pharmaceuticals Holdings | Cardiff Oncology vs. PDS Biotechnology Corp | Cardiff Oncology vs. Reviva Pharmaceuticals Holdings | Cardiff Oncology vs. Eyenovia |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Other Complementary Tools
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data |